The current epidemic of chronic obstructive pulmonary disease (COPD) has produced a
worldwide health care burden, approaching that imposed by transmittable infectious …

Inflammation is a network of complex processes involving a variety of metabolic and
signaling pathways aiming at healing and repairing damage tissue, or fighting infection …

Chronic obstructive pulmonary disease (COPD) is a global health problem. The current
therapies for COPD are poorly effective and the mainstays of pharmacotherapy are …

Circulating endothelial microparticles (EMPs) are emerging as biomarkers of chronic
obstructive pulmonary disease (COPD) in individuals exposed to cigarette smoke (CS), but …

Copper‐zinc superoxide dismutase (Cu, Zn‐SOD) plays a protective role in various types of
tissue protecting them from oxidative damage. Alterations in Cu, Zn‐SOD (SOD 1 and SOD …

Simple Summary Diclofenac is a widely used drug for its anti-inflammatory and pain
alleviating properties. This review summarizes the current understanding about the drug …

The bioactive sphingolipid ceramide 1-phosphate (C1P) regulates key physiologic cell
functions and is implicated in a number of metabolic alterations and pathological processes …

The epithelial and endothelial cells lining the alveolus form a barrier essential for the
preservation of the lung respiratory function, which is, however, vulnerable to excessive …

Sphingolipid bioactivities in the respiratory airways and the roles of the proteins that handle
them have been extensively investigated. Gas or inhaled particles or microorganisms come …

Rationale: Cigarette smoke is the major risk factor in the development of chronic obstructive
pulmonary disease (COPD). Lipidomics is a novel and emerging research field that may …